Pluristem Therapeutics CEO Yaky Yanay's 2022 pay falls 86% to $1.3M
Pluristem Therapeutics reports 2022 executive compensation
By ExecPay News
Published: February 27, 2023
Pluristem Therapeutics reported fiscal year 2022 executive compensation information on February 27, 2023.
In 2022, three executives at Pluristem Therapeutics received on average a compensation package of $1M, a 85% decrease compared to previous year.
Average pay of disclosed executives at Pluristem Therapeutics
Yaky Yanay, Chief Executive Officer, received $1.3M in total, which decreased by 86% compared to 2021.
Zami Aberman, Chairman, received a compensation package of $1.2M, which decreased by 88% compared to previous year. 63% of the compensation package, or $751K, was in other compensation.
Chen Franco-Yehuda, Chief Financial Officer, earned $608K in 2022, a 55% decrease compared to previous year.
Pluristem Therapeutics' fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on February 27, 2023.